Surmodics, Inc. (SRDX)

Nov 19, 2025 - SRDX was delisted (reason: acquired by GTCR affiliate)

42.98

+0.15 (0.35%)

Inactive · Last trade price on Nov 18, 2025

Revenue by Product

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017
Medical Device	97.51M
Medical Device Growth	-7.82%
In Vitro Diagnostics	28.57M
In Vitro Diagnostics Growth	6.60%

Revenue by Geography

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Sep '19 Sep 30, 2019	Sep '18 Sep 30, 2018	Sep '17 Sep 30, 2017
United States	104.64M
United States Growth	-3.75%
Foreign	21.43M
Foreign Growth	-10.19%